Innovent Biologics, Inc.

OTCPK:IVBX.F Stock Report

Market Cap: US$8.1b

Innovent Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:IVBX.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Oct 24SellUS$39,665,163JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany8,668,935US$4.58
29 Oct 24BuyUS$22,367,077JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,592,813US$4.87
10 Oct 24SellUS$68,722,897JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany10,891,140US$6.31
08 Oct 24BuyUS$70,495,950JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany11,412,177US$6.18
02 Oct 24SellUS$10,454,736De-Chao YuIndividual1,750,000US$6.02
30 Sep 24SellUS$9,084,814De-Chao YuIndividual1,500,000US$6.10
27 Sep 24SellUS$4,330,187Hao Xi EdeIndividual736,500US$5.88
26 Sep 24SellUS$469,386Hao Xi EdeIndividual81,500US$5.76
11 Sep 24BuyUS$11,040JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,000US$5.52
11 Sep 24BuyUS$11,040JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany2,000US$5.52
11 Sep 24SellUS$223,559JP Morgan Asset ManagementCompany40,500US$5.52
11 Sep 24SellUS$85,461,245JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany15,482,177US$5.52
10 Sep 24BuyUS$57,544,602JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany10,624,087US$5.42
10 Jul 24SellUS$12,728,577Capital Research and Management CompanyCompany2,755,000US$4.62
03 May 24SellUS$4,683,731De-Chao YuIndividual906,250US$5.17
02 Feb 24BuyUS$7,773,313Capital Research and Management CompanyCompany1,869,776US$4.16
12 Jan 24BuyUS$6,636,262Capital Research and Management CompanyCompany1,292,500US$5.13
05 Jan 24SellUS$17,121,093Capital Research and Management CompanyCompany3,456,000US$4.95

Insider Trading Volume

Insider Buying: IVBX.F insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of IVBX.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,614,5000.648%
VC/PE Firms89,475,3505.46%
Individual Insiders110,666,8236.76%
General Public674,115,72741.2%
Institutions753,037,44646%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 48.76% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.92%
Capital Research and Management Company
113,425,003US$561.1m-0.65%0.02%
6.53%
De-Chao Yu
107,003,778US$529.3m-1.61%no data
5.46%
SDIC Innovation Investment Management Co., Ltd.
89,475,350US$442.6m0%25.24%
3.56%
The Vanguard Group, Inc.
58,328,314US$288.5m-0.2%no data
3.38%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
55,364,540US$273.9m0%46.32%
2.63%
BlackRock, Inc.
43,014,251US$212.8m0.59%no data
2.22%
GF Fund Management Co., Ltd.
36,440,000US$180.3m0%0.35%
1.98%
Norges Bank Investment Management
32,441,094US$160.5m0%0.01%
1.84%
Fidelity International Ltd
30,169,499US$149.2m0.09%0.06%
1.82%
Temasek Holdings (Private) Limited
29,751,000US$147.2m136%0.12%
1.52%
Citigroup Inc.,Banking and Securities Investments
24,932,063US$123.3m0%0.08%
1.46%
Bosera Asset Management Co., Ltd.
23,965,000US$118.6m0%0.48%
1.43%
Harvest Fund Management Co. Ltd.
23,397,288US$115.7m0%0.23%
1.14%
E Fund Management Co., Ltd.
18,603,000US$92.0m0%0.1%
0.87%
Lav Advanced Management Company Limited
14,276,500US$70.6m0%74.72%
0.83%
JPMorgan Chase & Co, Brokerage and Securities Investments
13,674,179US$67.6m93.8%0.03%
0.83%
FMR LLC
13,572,079US$67.1m-11.7%no data
0.73%
China Asset Management Co. Ltd.
11,944,751US$59.1m-0.96%0.06%
0.63%
Schroder Investment Management Limited
10,295,500US$50.9m0%0.03%
0.57%
Schroder Investment Management North America Inc.
9,257,000US$45.8m5.86%0.13%
0.54%
Polar Capital Holdings Plc
8,812,894US$43.6m3.06%0.16%
0.51%
ICBC Credit Suisse Asset Management Co., Ltd.
8,343,974US$41.3m0%0.2%
0.5%
Invesco Ltd.
8,134,000US$40.2m1.31%0.01%
0.45%
LAV Investment Adviser Limited
7,345,000US$36.3m0%29.28%
0.41%
Fullerton (Private) Limited
6,673,500US$33.0m0%no data